临床研究
Copyright ©The Author(s) 2018.
世界华人消化杂志. 2018-04-28; 26(12): 707-715
在线出版 2018-04-28. doi: 10.11569/wcjd.v26.i12.707
表1 3组一般资料[ (mean ± SD)或Median (IQR)]比较
无肝纤维化 (n = 44)早期肝纤维化 (n = 26)进展期肝纤维化 (n = 35)统计量P
年龄 (岁)40.05 ± 11.1338.60 ± 13.9244.69 ± 13.390.8380.436
BMI (kg/m2)22.96 (21.43-26.05)23.23 (20.31-24.84)23.45 (21.62-25.93)0.3040.859
LSM (kPa)8.48 (7.00-9.85)9.4 (6.4-11.30)12.75 (9.80-20.75)20.4990.000
HA (ng/mL)60.72 (28.45-107.52)98.19 (28.82-232.79)60.10 (29.61-165.84)1.4240.491
LN (ng/mL)113.37 (75.55-172.73)99.61 (78.53-192.88)127.67 (99.30-158.48)1.3200.517
CⅣ (ng/mL)55.84 (31.99-83.82)55.81 (27.36-89.09)69.11 (43.06-123.28)2.9130.233
PCⅢ (ng/mL)80.11 (54.34-111.65)70.01 (44.30-104.00)103.87 (73.69-143.70)2.2500.325
hui氏评分0.09 (0.04-0.21)0.15 (0.05-0.37)0.46 (0.23-0.85)20.0840.000
Forns指数7.04 (5.80-7.97)6.74 (5.59-8.44)8.80 (7.62-11.15)14.3700.001
FIB-41.22 (0.82-1.62)1.11 (0.80-1.59)2.42 (1.43-4.97)12.4510.002
NFS-2.67 (-3.33-2.14)-2.57 (-3.28-1.70)-1.12 (-2.48-0.08)12.4200.002
表2 各纤维化评估模型间的相关性分析
HALNCⅣPCⅢhui氏评分Forns指数FIB-4NFS
LSMr0.1940.1340.2560.2290.4560.4290.3610.388
P0.0480.1740.0080.0190.0000.0000.0000.000
HAr0.0350.2380.1590.2750.2890.3060.288
P0.7230.0140.1050.0050.0030.0010.003
LNr0.5140.4320.1240.0630.1790.111
P0.0000.0000.2070.5210.0680.258
CⅣr0.7040.3910.3520.3560.282
P0.0000.0000.0000.0000.004
PCⅢr0.4000.3730.3620.301
P0.0000.0000.0000.002
hui氏评分r0.8100.7160.844
P0.0000.0000.000
Forns指数r0.8980.893
P0.0000.000
FIB-4r0.899
P0.000
表3 无创纤维化评估模型对慢性乙型肝炎病毒感染者肝纤维化的效能评估
AUCCut-off值Se (%)Sp (%)PPV (%)NPV (%)符合率 (%)
LSM0.76411.650.600.910.780.830.82
HA0.55426.600.910.240.360.810.45
CⅣ (ng/mL)0.60037.900.830.330.360.770.48
PCⅢ (ng/mL)0.590112.710.430.760.470.740.66
hui氏评分0.7530.220.740.700.520.830.70
Forns指数0.7248.000.710.740.560.840.72
FIB-40.7111.660.690.770.580.830.73
NFS0.704-1.250.540.890.700.810.78

引文著录: 冷雪君, 颜学兵. FibroTouch®无创肝脏硬度测定值与血清标志物对慢性乙型肝炎患者肝纤维化程度评估的相关性分析. 世界华人消化杂志 2018; 26(12): 707-715